Literature DB >> 12220225

Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.

Nicholas R D Paling1, Melanie J Welham.   

Abstract

The tyrosine phosphatase SHP-1 (Src homology phosphatase-1) has been widely implicated as a negative regulator of signalling in immune cells. We have investigated in detail the role of SHP-1 in interleukin-3 (IL-3) signal transduction by inducibly expressing wild-type (WT), C453S (substrate-trapping) and R459M (catalytically inactive) forms of SHP-1 in the IL-3-dependent cell line BaF/3. Expression of WT SHP-1 had little impact on IL-3-induced proliferation, but enhanced apoptosis following IL-3 withdrawal. Expression of R459M SHP-1 increased the proliferative response of BaF/3 cells to IL-3 and increased cell survival at low doses of IL-3 and following IL-3 withdrawal. Investigation into the biochemical consequences resulting from expression of these SHP-1 variants demonstrated that the beta chain of the IL-3 receptor (Aic2A) was hypo-phosphorylated in cells expressing WT SHP-1 and hyper-phosphorylated in those expressing R459M SHP-1. Further, ectopic expression of the trapping mutant, C453S SHP-1, protected Aic2A from dephosphorylation, suggesting that Aic2A is a SHP-1 substrate in BaF/3 cells. Examination of overall levels of tyrosine phosphorylation demonstrated that they were not perturbed in these transfectants. Activation-specific phosphorylation of STAT (signal transducer and activator of transcription) 5a/b, protein kinase B and ERK (extracellular-signal-regulated kinase)-1 and -2 was also unaffected by expression of WT or R459M SHP-1. However, overall levels of IL-3-induced tyrosine phosphorylation of STAT5 were reduced upon expression of WT SHP-1 and increased when R459M SHP-1 was expressed, consistent with STAT5 being a potential SHP-1 substrate. These results demonstrate that SHP-1 acts to negatively regulate IL-3-driven survival and proliferation, potentially via regulation of tyrosine phosphorylation of Aic2A and STAT5.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220225      PMCID: PMC1223032          DOI: 10.1042/BJ20021054

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

Review 1.  STAT proteins and transcriptional responses to extracellular signals.

Authors:  C M Horvath
Journal:  Trends Biochem Sci       Date:  2000-10       Impact factor: 13.807

2.  Molecular interactions of SHP1 and SHP2 in IL-3-signalling.

Authors:  Helen Wheadon; Nicholas R D Paling; Melanie J Welham
Journal:  Cell Signal       Date:  2002-03       Impact factor: 4.315

Review 3.  The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells.

Authors:  D Metcalf
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

4.  Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev).

Authors:  G Van Zant; L Shultz
Journal:  Exp Hematol       Date:  1989-02       Impact factor: 3.084

5.  Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation.

Authors:  C L Yu; Y J Jin; S J Burakoff
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

6.  Mutation of the hematopoietic cell phosphatase (Hcph) gene is associated with resistance to gamma-irradiation-induced apoptosis in Src homology protein tyrosine phosphatase (SHP)-1-deficient "motheaten" mutant mice.

Authors:  H C Hsu; L D Shultz; X Su; J Shi; P A Yang; M J Relyea; H G Zhang; J D Mountz
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

7.  Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines.

Authors:  M K Pathak; T Yi
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

8.  Phosphoinositide 3-kinase-dependent regulation of interleukin-3-induced proliferation: involvement of mitogen-activated protein kinases, SHP2 and Gab2.

Authors:  B L Craddock; J Hobbs; C E Edmead; M J Welham
Journal:  J Biol Chem       Date:  2001-05-02       Impact factor: 5.157

9.  Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation.

Authors:  A L Mui; H Wakao; T Kinoshita; T Kitamura; A Miyajima
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

10.  An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT.

Authors:  N W Roehm; G H Rodgers; S M Hatfield; A L Glasebrook
Journal:  J Immunol Methods       Date:  1991-09-13       Impact factor: 2.303

View more
  20 in total

Review 1.  The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.

Authors:  Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

2.  Promoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS glia.

Authors:  George P Christophi; Chad A Hudson; Ross Gruber; Christoforos P Christophi; Paul T Massa
Journal:  J Neurochem       Date:  2008-06-01       Impact factor: 5.372

3.  Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5.

Authors:  Wenbin Xiao; Hong Hong; Yuko Kawakami; Clifford A Lowell; Toshiaki Kawakami
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

Review 4.  Protein tyrosine phosphatases in the JAK/STAT pathway.

Authors:  Dan Xu; Cheng-Kui Qu
Journal:  Front Biosci       Date:  2008-05-01

Review 5.  Protein tyrosine phosphatases as wardens of STAT signaling.

Authors:  Frank-D Böhmer; Karlheinz Friedrich
Journal:  JAKSTAT       Date:  2014-02-20

6.  Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).

Authors:  Helen Wheadon; Christine Edmead; Melanie J Welham
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

7.  Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.

Authors:  Wenbin Xiao; Hong Hong; Yuko Kawakami; Yuko Kato; Dianqing Wu; Hiroki Yasudo; Akiko Kimura; Hiromi Kubagawa; Luigi F Bertoli; Randall S Davis; Luan A Chau; Joaquin Madrenas; Cyrus C Hsia; Anargyros Xenocostas; Thomas J Kipps; Lothar Hennighausen; Atsushi Iwama; Hiromitsu Nakauchi; Toshiaki Kawakami
Journal:  Cancer Cell       Date:  2009-08-04       Impact factor: 31.743

8.  Elevated postinjury thrombospondin 1-CD47 triggering aids differentiation of patients' defective inflammatory CD1a+dendritic cells.

Authors:  Gautam Bandyopadhyay; Sanjukta Bandyopadhyay; Paul E Bankey; Carol L Miller-Graziano
Journal:  J Leukoc Biol       Date:  2014-07-07       Impact factor: 4.962

9.  Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumors.

Authors:  Edmund K Moon; Liang-Chuan Wang; Douglas V Dolfi; Caleph B Wilson; Raghuveer Ranganathan; Jing Sun; Veena Kapoor; John Scholler; Ellen Puré; Michael C Milone; Carl H June; James L Riley; E John Wherry; Steven M Albelda
Journal:  Clin Cancer Res       Date:  2014-06-11       Impact factor: 12.531

10.  SHP-1 deficient mast cells are hyperresponsive to stimulation and critical in initiating allergic inflammation in the lung.

Authors:  Li Zhang; Sun Young Oh; Xinxing Wu; Min Hee Oh; Fan Wu; John T Schroeder; Clifford M Takemoto; Tao Zheng; Zhou Zhu
Journal:  J Immunol       Date:  2009-12-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.